Turning Swords Into Plowshares: Transglutaminase to Detoxify Gluten

Gastroenterology

Volumn 133, Issue 3, 2007, Pages 1025-1028

  Schuppan, Detlef ^a   Junker, Yvonne ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE ANTIBODY; GLUTEN; INTERLEUKIN 10; INTERLEUKIN 15 ANTIBODY; PROLYL ENDOPEPTIDASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; UNCLASSIFIED DRUG;

CELIAC DISEASE; EDITORIAL; ENTEROPATHY; ENZYME THERAPY; GLUTEN FREE DIET; HUMAN; IMMUNE RESPONSE; INFLAMMATION; PREVALENCE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 34548490278     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.07.039     Document Type: Editorial

References (42)

1. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 119 (2000) 234-242
2. Ciclitira P.J., King A.L., and Fraser J.S. AGA technical review on celiac sprue. American Gastroenterological Association. Gastroenterology 120 (2001) 1526-1540
3. Green P.H., and Jabri B. Coeliac disease. Lancet 362 (2003) 383-391
4. Fasano A., and Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 120 (2001) 636-651
5. Maki M., Mustalahti K., Kokkonen J., et al. Prevalence of celiac disease among children in Finland. N Engl J Med 348 (2003) 2517-2524
6. Dieterich W., Ehnis T., Bauer M., et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3 (1997) 797-801
7. Lorand L., and Graham R.M. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4 (2003) 140-156
8. Dieterich W., Esslinger B., Trapp D., et al. Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease. Gut 55 (2006) 478-484
9. Wieser H. Chemistry of gluten proteins. Food Microbiol 24 (2007) 115-119
10. Schuppan D., Dieterich W., Ehnis T., et al. Identification of the autoantigen of celiac disease. Ann N Y Acad Sci 859 (1998) 121-126
11. Arentz-Hansen H., Korner R., Molberg O., et al. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 191 (2000) 603-612
12. Molberg O., McAdam S.N., Korner R., et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 4 (1998) 713-717
13. van de Wal Y., Kooy Y., van Veelen P., et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 161 (1998) 1585-1588
14. Sollid L.M., and Khosla C. Future therapeutic options for celiac disease. Nat Clin Pract Gastroenterol Hepatol 2 (2005) 140-147
15. Logan R.F., Rifkind E.A., Turner I.D., et al. Mortality in celiac disease. Gastroenterology 97 (1989) 265-271
16. Howdle P.D., Jalal P.K., Holmes G.K., et al. Primary small-bowel malignancy in the UK and its association with coeliac disease. QJM 96 (2003) 345-353
17. Ventura A., Magazzu G., and Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 117 (1999) 297-303
18. Hausch F., Shan L., Santiago N.A., et al. Intestinal digestive resistance of immunodominant gliadin peptides. Am J Physiol Gastrointest Liver Physiol 283 (2002) G996-G1003
19. Pyle G.G., Paaso B., Anderson B.E., et al. Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue. Clin Gastroenterol Hepatol 3 (2005) 687-694
20. Koning F., and Vader W. Gluten peptides and celiac disease. Science 299 (2003) 513-515 author reply 513-515
21. Matysiak-Budnik T., Candalh C., Cellier C., et al. Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease. Gastroenterology 129 (2005) 786-796
22. Cerf-Bensussan N., Matysiak-Budnik T., Cellier C., et al. Oral proteases: a new approach to managing coeliac disease. Gut 56 (2007) 157-160
23. Stepniak D., Spaenij-Dekking L., Mitea C., et al. Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease. Am J Physiol Gastrointest Liver Physiol 291 (2006) G621-G629
24. Di Cagno R., De Angelis M., Lavermicocca P., et al. Proteolysis by sourdough lactic acid bacteria: effects on wheat flour protein fractions and gliadin peptides involved in human cereal intolerance. Appl Environ Microbiol 68 (2002) 623-633
25. Di Cagno R., De Angelis M., Auricchio S., et al. Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients. Appl Environ Microbiol 70 (2004) 1088-1096
26. Kiyosaki T., Matsumoto I., Asakura T., et al. Gliadain, a gibberellin-inducible cysteine proteinase occurring in germinating seeds of wheat, Triticum aestivum L., specifically digests gliadin and is regulated by intrinsic cystatins. FEBS J 274 (2007) 1908-1917
27. Siegel M., Bethune M.T., Gass J., et al. Rational design of combination enzyme therapy for celiac sprue. Chem Biol 13 (2006) 649-658
28. Vader L.W., Stepniak D.T., Bunnik E.M., et al. Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology 125 (2003) 1105-1113
29. Spaenij-Dekking L., Kooy-Winkelaar Y., van Veelen P., et al. Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients. Gastroenterology 129 (2005) 797-806
30. Watts T., Berti I., Sapone A., et al. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci U S A 102 (2005) 2916-2921
31. Schuppan D., and Hahn E.G. Biomedicine. Gluten and the gut-lessons for immune regulation. Science 297 (2002) 2218-2220
32. Choi K., Siegel M., Piper J.L., et al. Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2. Chem Biol 12 (2005) 469-475
33. Kim C.Y., Quarsten H., Bergseng E., et al. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci U S A 101 (2004) 4175-4179
34. Salvati V.M., Mazzarella G., Gianfrani C., et al. Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa. Gut 54 (2005) 46-53
35. Villadsen L.S., Schuurman J., Beurskens F., et al. Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. J Clin Invest 112 (2003) 1571-1580
36. Gianfrani C., Siciliano R.A., Facchiano A.M., et al. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease. Gastroenterology 133 (2007) 780-789
37. Anderson R.P., Degano P., Godkin A.J., et al. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 6 (2000) 337-342
38. Shan L., Molberg O., Parrot I., et al. Structural basis for gluten intolerance in celiac sprue. Science 297 (2002) 2275-2279
39. Pasternack R., Dorsch S., Otterbach J.T., et al. Bacterial pro-transglutaminase from Streptoverticillium mobaraense-purification, characterisation and sequence of the zymogen. Eur J Biochem 257 (1998) 570-576
40. Yokoyama K., Nio N., and Kikuchi Y. Properties and applications of microbial transglutaminase. Appl Microbiol Biotechnol 64 (2004) 447-454
41. Vader W., Kooy Y., Van Veelen P., et al. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 122 (2002) 1729-1737
42. Maiuri L., Ciacci C., Ricciardelli I., et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 362 (2003) 30-37